✦ LIBER ✦

Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection

Book ID: 127251146
Publisher: American Academy of Pediatrics
Year: 2014
Tongue: English
Weight: 833 KB
Volume: 134
Category: Article
ISSN: 0031-4005
DOI: 10.1542/peds.2014-1666

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The risk of mortality among young childr

The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection

✍ Szabo, Shelagh M.; Gooch, Katherine L.; Bibby, Meagan M.; Vo, Pamela G.; Mitchel 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Evaluation of the Safety of Palivizumab

Evaluation of the Safety of Palivizumab in the Second Season of Exposure in Young Children at Risk for Severe Respiratory Syncytial Virus Infection

✍ Thierry Lacaze-Masmonteil, Juergen Seidenberg, Ian Mitchell, Veerle Cossey, Mart 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 116 KB

Cost-Effectiveness Analysis of Palivizum

Cost-Effectiveness Analysis of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Infection in High-Risk Late Preterm Infants in the Netherlands

✍ Langenfeld, M.K.; Visser, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB